reference/2253436

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/2253436

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Clinical Trial, Phase III\|Journal Article\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	280
issn	0041-1337
issueIdentifier	2
pageRange	271-280
publicationName	Transplantation
startingPage	271
bibliographicCitation	MacDonald AS; RAPAMUNE Global Study Group. A worldwide, phase III, randomized, controlled, safety and efficacy study of a sirolimus/cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allografts. Transplantation. 2001 Jan 27;71(2):271–80. doi: 10.1097/00007890-200101270-00019. PMID: 11213073.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_75ff1a516855a5f196bfbda60b44b5df
date	2001-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1097/00007890-200101270-00019 https://pubmed.ncbi.nlm.nih.gov/11213073
isPartOf	https://portal.issn.org/resource/ISSN/0041-1337 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/7838
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	A WORLDWIDE, PHASE III, RANDOMIZED, CONTROLLED, SAFETY AND EFFICACY STUDY OF A SIROLIMUS/CYCLOSPORINE REGIMEN FOR PREVENTION OF ACUTE REJECTION IN RECIPIENTS OF PRIMARY MISMATCHED RENAL ALLOGRAFTS
discusses	http://id.nlm.nih.gov/mesh/M0025279 http://id.nlm.nih.gov/mesh/M0029863
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D020123Q000627 http://id.nlm.nih.gov/mesh/D016572Q000627 http://id.nlm.nih.gov/mesh/D016030Q000276
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D006084Q000517 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D002102 http://id.nlm.nih.gov/mesh/D000293 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D006650 http://id.nlm.nih.gov/mesh/D004311 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D000208
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5497195 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID49867938 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25246316 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID132274082 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71306795 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8167 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123134263 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16404350 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284373 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71463825 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284616 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6435893 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID121225388 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73896891 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID162639143 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID129009974 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5458585 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24883466 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280754 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2909

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136314073 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID248766214

Total number of triples: 57.